| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.6 | 0.04 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.6 | 0.03 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.35 | 0.03 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.33 | 0.05 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.3 | 0.03 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.26 | 0.4 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.09 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.23 | 7e-09 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.22 | 0.1 |